Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-010561
Filing Date
2025-02-07
Accepted
2025-02-07 16:19:28
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm255864-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm255864-5_4seq1.xml 4 3992
  Complete submission text file 0001104659-25-010561.txt   5622
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5005 MCCONNELL AVENUE LOS ANGELES CA 90066
Business Address
Kyme Pierre (Reporting) CIK: 0002028892 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 25602021